Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 10 (MTND5P10) is a nuclear pseudogene with high sequence homology to the mitochondrial-encoded gene MT-ND5, which normally encodes a core subunit of mitochondrial respiratory chain Complex I (NADH:ubiquinone oxidoreductase). However, as a pseudogene, MTND5P10 does not encode a functional protein: it contains mutations and premature stop codons that preclude expression of an active protein product. Nuclear-embedded mitochondrial pseudogenes (NUMTs) such as this often arise through the integration of mitochondrial DNA fragments into the nuclear genome and do not participate in biological processes or serve as drug targets, unlike their mitochondrial counterparts. MT-ND5 (canonical, non-pseudogene) encodes a core subunit (ND5) of Complex I in the mitochondrial respiratory chain, essential for cellular ATP production and associated with a number of mitochondrial diseases when mutated. Pseudogenes such as MTND5P10 result from partial duplication, mutation, or mitochondrial-to-nuclear DNA transfer and are nonfunctional: they cannot compensate for defects in the parent mitochondrial gene, do not encode a protein product, and do not serve as therapeutic targets. There are no known drugs, mechanisms of action, clinical uses, or biomarker roles for pseudogene entries like MTND5P10. If the intent was to refer to the functional mitochondrial gene (MT-ND5, not MTND5P10), that is a legitimate enzyme target with clinical significance and links to disease. However, MTND5P10 (as specifically asked) is a non-coding, non-target pseudogene, and the query is best classified as concerning a non-target and does not correspond to a directly druggable protein or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 10 (MTND5P10).